The 2010 BioBusiness Asia (BBA) conference is to be held at Grand Hyatt, Taipei during July 20-21. Organized by the Industrial Technology Research Institute, the conference theme this year is “Energizing BioBusiness in Asia.”
A major feature of the conference will be the participation of Steven Burrill, CEO of Burrill & Company, the global venture capital firm focusing on biotech investments. Mr Burrill will share his vision about global biotech trends and will also explore the topic of biotech venture capital. Another feature will be the exploration of success factors in generic drug development by Allen Chao, former CEO of Watson Pharmaceuticals.
Venture capital experts from China, Japan, Germany, US, Australia and Taiwan will participate in the conference. They will exchange information and views about biotech developments in different countries. The conference will also include one-on-one “Business to Business Partnering” sessions between major international biotech companies, expected to number over 23.
BioBusines Asia has been attracting major players in the biotech industry since 2002 and has become the largest Asian platform for information exchange and meetings. Business models suited to the emerging biotech industry and strategies to leverage global resources are some of the key topics discussed during the sessions.
Of particular focus will be the insights generated for the future biotech opportunities in Taiwan and Greater China. Read the news release at MarketWatch
